ArticleLaryngoscope investigative otolaryngology2025
Characteristics of Cannabis Use Among Head and Neck Cancer Survivors.
Article in Laryngoscope investigative otolaryngology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Cannabis use among cancer survivors: a systematic review and meta-analysis.Archives of public health = Archives belges de sante publique · 2026Pooled it
- Characteristics of Cannabis Use Among Head and Neck Cancer Survivors.Laryngoscope investigative otolaryngology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Understand the characteristics of cannabis use, including frequency, mode, and purpose, among head and neck cancer (HNC) survivors. Methods: A cross-sectional survey was distributed using ResearchMatch and online support groups for survivors of HNC. Respondents answered questions regarding demographics, cancer history, cannabis use, and knowledge of cannabis and completed a Short Form-12 Questionnaire. Multivariate logistic regression and descriptive statistics were utilized for analysis. Results: Of 92 respondents, 75% were current or former cannabis users and 25% were never users. Cannabis users were less likely to have above-median household income (OR 0.115, 95% CI 0.0139-0.662) and live outside of the United States (OR 0.0697, 95% CI 0.0026-0.7404) than current or former users. 36.2% and 27.5% of cannabis users reported occasional (1-5 days/month) and daily use, respectively. The most common mode of use was in edible products (46.4%). The most common reasons for use were to treat pain (79.4%), improve sleep (76.5%), cope with stress (64.7%), and recreation (63.6%). 19.2% of respondents reported receiving information regarding cannabis use in relation to cancer. Of those who had received information, the most common sources were a physician treating cancer (38.1%), friends (33.3%), and cancer support groups (33.3%). 45.6% of respondents reported significant or very high interest in receiving information about cannabis use in relation to cancer. Conclusions: Cannabis use for treatment of cancer-associated symptoms and recreation is common among HNC survivors. Many survivors are interested in information regarding cannabis use, but few have received information from a reputable source. Level of Evidence: Level 4.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.